DiaSorin Molecular LLC

DiaSorin Molecular LLC is a privately held company based in Cypress, California, employing 341 individuals. The company generates an annual revenue of $1 billion. DiaSorin Molecular specializes in molecular diagnostic products, offering a comprehensive portfolio of targeted and syndromic tests distributed globally. Their product line includes Simplexa® Direct kits for targeted testing, covering conditions like congenital CMV, HSV 1 & 2, Flu A/B & RSV, COVID-19, and others. These kits are designed to be used with the LIAISON® MDX, a real-time PCR instrument capable of handling both small and large-scale testing needs. The company also offers VERIGENE® panels for syndromic testing, which provide rapid identification of pathogens responsible for various infectious diseases. DiaSorin Molecular differentiates itself by providing a sample-to-answer system with VERIGENE® and a range of Simplexa® Direct kits for targeted testing. Their commitment to customer support is demonstrated through comprehensive sales, service, and support solutions. For inquiries or further information, please visit their website at molecular.diasorin.com.